These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

473 related items for PubMed ID: 21212173

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Inducible nitric oxide synthase isoform is a key mediator of leukostasis and blood-retinal barrier breakdown in diabetic retinopathy.
    Leal EC, Manivannan A, Hosoya K, Terasaki T, Cunha-Vaz J, Ambrósio AF, Forrester JV.
    Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5257-65. PubMed ID: 17962481
    [Abstract] [Full Text] [Related]

  • 4. Effects of peroxisome proliferator-activated receptor gamma and its ligand on blood-retinal barrier in a streptozotocin-induced diabetic model.
    Muranaka K, Yanagi Y, Tamaki Y, Usui T, Kubota N, Iriyama A, Terauchi Y, Kadowaki T, Araie M.
    Invest Ophthalmol Vis Sci; 2006 Oct; 47(10):4547-52. PubMed ID: 17003451
    [Abstract] [Full Text] [Related]

  • 5. Chlorogenic acid ameliorates non-proliferative diabetic retinopathy via alleviating retinal inflammation through targeting TNFR1 in retinal endothelial cells.
    Ouyang H, Xie Y, Du A, Dong S, Zhou S, Lu B, Wang Z, Ji L.
    Int Immunopharmacol; 2024 Nov 15; 141():112929. PubMed ID: 39153307
    [Abstract] [Full Text] [Related]

  • 6. Intravitreal injection of corticosteroid attenuates leukostasis and vascular leakage in experimental diabetic retina.
    Tamura H, Miyamoto K, Kiryu J, Miyahara S, Katsuta H, Hirose F, Musashi K, Yoshimura N.
    Invest Ophthalmol Vis Sci; 2005 Apr 15; 46(4):1440-4. PubMed ID: 15790913
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of diabetic leukostasis and blood-retinal barrier breakdown with a soluble form of a receptor for advanced glycation end products.
    Kaji Y, Usui T, Ishida S, Yamashiro K, Moore TC, Moore J, Yamamoto Y, Yamamoto H, Adamis AP.
    Invest Ophthalmol Vis Sci; 2007 Feb 15; 48(2):858-65. PubMed ID: 17251488
    [Abstract] [Full Text] [Related]

  • 8. Α-Melanocyte-Stimulating Hormone Protects Early Diabetic Retina from Blood-Retinal Barrier Breakdown and Vascular Leakage via MC4R.
    Cai S, Yang Q, Hou M, Han Q, Zhang H, Wang J, Qi C, Bo Q, Ru Y, Yang W, Gu Z, Wei R, Cao Y, Li X, Zhang Y.
    Cell Physiol Biochem; 2018 Feb 15; 45(2):505-522. PubMed ID: 29402864
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Aquaporin 4 knockdown exacerbates streptozotocin-induced diabetic retinopathy through aggravating inflammatory response.
    Cui B, Sun JH, Xiang FF, Liu L, Li WJ.
    Exp Eye Res; 2012 May 15; 98():37-43. PubMed ID: 22449442
    [Abstract] [Full Text] [Related]

  • 12. Intravitreal injection of erythropoietin protects both retinal vascular and neuronal cells in early diabetes.
    Zhang J, Wu Y, Jin Y, Ji F, Sinclair SH, Luo Y, Xu G, Lu L, Dai W, Yanoff M, Li W, Xu GT.
    Invest Ophthalmol Vis Sci; 2008 Feb 15; 49(2):732-42. PubMed ID: 18235022
    [Abstract] [Full Text] [Related]

  • 13. Modulation of p75(NTR) prevents diabetes- and proNGF-induced retinal inflammation and blood-retina barrier breakdown in mice and rats.
    Mysona BA, Al-Gayyar MM, Matragoon S, Abdelsaid MA, El-Azab MF, Saragovi HU, El-Remessy AB.
    Diabetologia; 2013 Oct 15; 56(10):2329-39. PubMed ID: 23918145
    [Abstract] [Full Text] [Related]

  • 14. Scutellarin alleviates blood-retina-barrier oxidative stress injury initiated by activated microglia cells during the development of diabetic retinopathy.
    Mei X, Zhang T, Ouyang H, Lu B, Wang Z, Ji L.
    Biochem Pharmacol; 2019 Jan 15; 159():82-95. PubMed ID: 30447218
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The effect of total lignans from Fructus Arctii on Streptozotocin-induced diabetic retinopathy in Wistar rats.
    Zhang H, Gao Y, Zhang J, Wang K, Jin T, Wang H, Ruan K, Wu F, Xu Z.
    J Ethnopharmacol; 2020 Jun 12; 255():112773. PubMed ID: 32199990
    [Abstract] [Full Text] [Related]

  • 17. Characterization of azurocidin as a permeability factor in the retina: involvement in VEGF-induced and early diabetic blood-retinal barrier breakdown.
    Skondra D, Noda K, Almulki L, Tayyari F, Frimmel S, Nakazawa T, Kim IK, Zandi S, Thomas KL, Miller JW, Gragoudas ES, Hafezi-Moghadam A.
    Invest Ophthalmol Vis Sci; 2008 Feb 12; 49(2):726-31. PubMed ID: 18235021
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Modulation of the p75 neurotrophin receptor using LM11A-31 prevents diabetes-induced retinal vascular permeability in mice via inhibition of inflammation and the RhoA kinase pathway.
    Elshaer SL, Alwhaibi A, Mohamed R, Lemtalsi T, Coucha M, Longo FM, El-Remessy AB.
    Diabetologia; 2019 Aug 12; 62(8):1488-1500. PubMed ID: 31073629
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.